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The current healthcare system is hampered by a reductionist approach in which
diagnostics and interventions focus on a specific target, resulting in medicines that center
on generic, static phenomena while excluding inherent dynamic nature of biological
processes, let alone psychosocial parameters. In this essay, we present some limitations
of the current healthcare system and introduce the novel and potential approach of
combining ultra-weak photon emission (UPE) with metabolomics technology in order
to provide a dynamic readout of higher organizational systems. We argue that the
combination of metabolomics and UPE can bring a new, broader, view of health state and
can potentially help to shift healthcare toward more personalized approach that improves
patient well-being.
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INTRODUCTION
There is currently a global need for a change in the healthcare system, including healthcare policies.
Specifically, we have clearly reached the boundaries of our current system, and rising costs make
healthcare increasingly less affordable.
The past success of the healthcare system is based on a paradigm that—ironically—is
now a limitation. The discovery of penicillin in 1928 by Alexander Fleming started an era
of antibiotic development and laid the foundation for a “war against” system of healthcare.
Over the past century, this concept became increasingly popular and has been particularly
successful for treating acute illnesses. This paradigm is exemplified by terms commonly used
in modern medicine with prefixes and suffixes such as “anti-” (e.g., antibiotic), “-inhibitor”
(e.g., angiotensin-converting-enzyme inhibitor—ACE), and “-blocker” (e.g., beta-blocker). This
approach led to the development of a diseasemanagement system rather than a bona fide healthcare
system. Most importantly, this system largely overlooks chronic illness and preventive strategies
(Choi et al., 2005; Hunter, 2008).
Rather than extrapolating current disease management knowledge into disease prevention and
the promotion of health—a strategy that is likely to fail—we suggest that a radically different,
transformative approach is needed. This novel approach is based on a systems—or ecological—view
on health and well-being (Layard, 2005; Puska, 2008). With this approach, the focus shifts
naturally from a more reductionist, single-symptom approach to a dynamic perspective based
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on systems regulation. In addition, each individual patient is
considered in context, providing a more biopsychosocial view
rather than a strict biomedical perspective. Such a shift from
the traditional “one-size-fits-all” approach—which typically
leads to a “one-size-fits-none” outcome—to personalized
medicine/healthcare is a central theme in the new paradigm
referred to as “P4 Health”: Preventive, Predictive, Personalized,
Participatory healthcare (Hood and Friend, 2011).
In a health ecosystem, human-human interactions are the
most important basis, with compassion and respect for each
other’s world view serving as the central theme (van der Greef
et al., 2010). Moreover, politicians and policy-makers must
change their focus from a short-term “quick-fix” approach, which
is typically driven by short-term electoral cycles, to achieving
long-term, sustainable improvements in our healthcare system
at the societal level. The drastic, wide-reaching effects of our
changing lifestyle on health and well-being—which has created
the so-called “diseases of comfort”—must be considered from
a much wider perspective, requiring an approach that crosses
cultures as well as disciplines. This approach will improve
integrative medicine and facilitate health-focused prevention,
thereby reaffirming the importance of the relationship between
the physician and patient by focusing on the whole person;
moreover, this approach will be evidence-based and will integrate
all appropriate therapeutic and lifestyle strategies, healthcare
system, and disciplines in order to achieve optimal health
and healing (Academic Consortium for Integrative Medicine &
Health, 2016).
From the perspective of diagnostics, current approaches focus
only on a single time point or a limited number of time
points; however, human physiology is based on a wide spectrum
of endogenous biological rhythms and oscillations (Muehsam
and Ventura, 2014). Such rhythms serve as a fingerprint
representing higher-order dynamic systems and various time
scales ranging from long periods such as diurnal/nocturnal,
monthly, seasonal, and annual rhythms to short periods on
the order of minutes, seconds, or fractions of seconds. In this
context, human physiology tends to maintain a homeostatic
state due to a complex network of regulatory feedback circuits
driven by various rhythms. Therefore, homeostasis and allostasis
go hand-in-hand with dynamic systems concepts (Sterling,
2012; van der Greef et al., 2013), and changes in oscillation
patterns and/or rhythms can indicate a perturbation in the
system. Indeed, evidence suggests that examining one’s biological
clock might help with determining a clinical diagnosis (Most
et al., 2010). However, current clinical biochemistry tools
are limited with respect to bridging different rhythmic time
scales. Therefore, methods for measuring ultra-weak photon
emissions (UPE) have been developed and appear to be suitable
for measuring systems dynamics. In addition, UPE can be
measured in real time and is non-invasive, label-free, and cost-
effective.
A growing body of evidence suggests that UPE reflects
the coherence of self-organizing systems and might therefore
be used to measure health at a higher organizational level
(Bajpai et al., 2013; de Mello Gallep, 2014; Van Wijk et al.,
2014), providing a novel tool for reading the state of dynamic
biological systems. UPE is intrinsic to every living system
that undergoes respiration and utilizes oxygen; therefore, the
dynamics of UPE reflect the biological processes that underlie
this emission (Cifra and Pospíšil, 2014; Pospíšil et al., 2014;
van Wijk, 2014). We therefore suggest that UPE may be
combined with metabolomics technologies in order to develop
an integrated diagnostic tool for detecting the transition from
health to disease by combining the sensitivity of biochemical
pattern recognition with the high temporal resolution of UPE
measurement.
Metabolomics has been described as the comprehensive
analysis of all metabolites in a biological sample (e.g., cells,
tissues, and/or bodily fluids; German et al., 2005; Ramautar et al.,
2013). Together with other omics technologies (i.e., genomics,
transcriptomics, and proteomics), metabolomics provides a
holistic picture of the metabolic phenotype (Beger et al., 2016).
The major advantage of using metabolomics over other omics
technologies is the ability to investigate dynamic regulatory
mechanisms at the molecular level, providing insight into how
distinct biochemical pathways are interconnected (German et al.,
2005). Thus, a more personalized approach to health assessment
can be achieved.
In addition, new ideas regarding systems-based thinking have
appeared, accelerating our understanding of concepts regarding
the complexities of life (Oltvai and Barabási, 2002). Nevertheless,
our healthcare system’s current focus on disease management
using a reductionist approach does not consider influences of
the biopsychosocial environment. Moreover, novel fundamental
advances in our understanding of the dynamics of life have
led to the development of a new biological picture. In this
view, the organizational metabolic network is represented as a
hierarchical model (i.e., as a pyramid; see Figure 1). Another
newly recognized feature is the dynamic, oscillatory aspect of
metabolic flows, in which metabolic regulatory information is
controlled by repetitive, pulsing dynamic systems (Adachi et al.,
1999).
In this essay, we address the potential new diagnostic tools
as a stepping stone toward realizing novel intervention-based
strategies in a health ecosystem based on promoting the healthy
state (i.e., salutogenesis). The salutogenesis concept has been
used in many health practices. The concept can be seen as
complementary to the biomedical model as it focuses on the
complex self-healing processes rather than concentrating on a
singular pathogenic factor (Antonovsky, 1984; Lindstrom and
Eriksson, 2005).
MOVING TOWARD A NEW VISION
Our current medical system is based on pathogenesis, defining
disease, and developing standardized treatments. However, the
cornerstones of the healthcare system of the future will be the
definition of health, the ability to monitor changes in health
status, and the ability to provide evidence-based interventions
that improve health at both the population (i.e., generic) level
and at the individual patient level (van der Greef et al., 2006).
In recent years, a large number of publications have focused on
establishing a new definition of health, thereby departing from
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FIGURE 1 | Schematic depiction of the development from health into a disease state. It shows how challenges to homeostasis can be regulated by allostasis
by adapting the set points of the regulatory system. If the resilience is lost over time, the system can develop into a disease state. The last part is often handled by
disease management focusing on single symptoms. The “life pyramid” view represents the notion of how biological systems are interconnected at different
organizational levels and how the biopsychosocial environment acts dynamically within the system and therefore reflects the information at the lower levels. This
integrated picture is more applicable to the pre-disease and healthy state and represents the newly emerging picture of how the future healthcare system should focus
on promoting health rather than treating disease. Adapted from Oltvai and Barabási (2002), Ramautar et al. (2013), and van der Greef et al. (2013).
the current static WHO definition toward a dynamic definition
of health (Bircher, 2005; Lancet, 2009; Huber et al., 2011).
As illustrated in Figure 1, health can be depicted as the
dynamic behavior between a physiological range, indicated by
homeostasis and allostasis in normal daily life with physical,
psychological, and social challenges and rhythms. The allostasis
concept describes the system’s response to an environmental
challenge by anticipating, preparing for, and controlling the
challenge (Sterling, 2012). When the challenge is over and the
environment is restored to previous conditions, the system
returns to its normal state. However, if the system cannot return
to its healthy state, the system can enter a disease state, which
can even become irreversible in an advanced stage (Ramautar
et al., 2013; van der Greef et al., 2013). In addition, the “life
pyramid” depicted in Figure 1 is integrated, underscoring the
need to reach higher overarching network dynamics in order
to develop optimal strategies for promoting health. Because
health is dependent upon the environment (as discussed above),
this higher level organization must be studied from a broad
perspective that includes the dynamic interactions between the
human body and its psychosocial environment.
The key feature of this view is that the system can restore
itself via self-regulatorymechanisms, therebymaintaining health,
whereas disease develops when the system loses this ability. In
other words, in a disease situation, the system loses its ability
to recover fully. In this situation, a strategy for promoting
health is needed that differs fundamentally from the current
strategy designed to simply manage disease. For this reason,
preventive strategies that use pathology-based methodologies are
not applicable, and we should not focus on a change in the
concentration of a given molecule (for example, glucose). Thus,
with type 2 diabetes, for example, we must focus on dynamic
regulatory mechanisms in the system’s response to a challenge
(e.g., an oral glucose tolerance test). Such strategies have
been developed recently using metabolomics-based strategies
(Wopereis et al., 2009; van Ommen et al., 2014); however,
the need still exists for a dynamic tool that can integrate,
interpret, and correlate detailed information regarding regulatory
mechanisms with a higher level of systems-based thinking.
Systems-based thinking has developed through systems
biology in life sciences and is used to study organizations in a
wider context. An important feature of systems-based thinking
is its focus on relationships rather than individual variables (van
der Greef et al., 2007). In such a view, the relationships between
biological, psychological, social, and environmental factors—and
changes in these relationships over time—are central features. By
considering the complexity of these interactions, we can develop
a personalized approach that is applicable in the context of the
individual. This approach is centered on achieving an optimal
relationship between the patient and the healthcare provider.
Metabolomics technologies are used to measure metabolite
profiles in bodily fluids, thus reflecting the complex interaction
between the environment and the body (van der Greef et al.,
2013). To date, most system-wide measurements have been
interpreted at the “medium-to-low” level of the triangle (see
Figure 1) using metabolomics. Indeed, dynamic measurements
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of metabolites can give insight into the development of diseases
and the early stages of metabolic dysfunction (Snyderman, 2012).
Extremely early changes at higher levels are believed to be
responsible for a shift toward disease, and detecting these changes
is essential in order to develop prevention-based strategies to
promote health. Indeed, measuring a system’s coherence may
serve as a tool for measuring the system’s resilience and the
individual’s homeostatic and allostatic capacity.
Recent evidence suggests that recording metabolic shifts by
measuring UPE-related metabolic processes in the human body
can reflect the dynamics of metabolic organization (Bajpai et al.,
2013; Van Wijk et al., 2014). Photobiological response (the result
of chemical and/or physical changes induced by light in biological
systems) and low-level biological luminescence (the production
and emission of photons) are considered to be complementary
manifestations of the photons’ role in metabolism. Thus, the
recorded photon emissions reflect the net activity of a subset of
these reactions, thereby reflecting the body’s current metabolic
state. UPE may therefore serve as a suitable complementary tool
for analyzing a biological dynamic system in combination with
metabolomics technology.
UPE is present in all living organisms (van Wijk, 2014) and
is low-intensity (non-thermal) light emitted from living systems
without the use of an external intervention (Devaraj et al., 1997;
Schwabl and Klima, 2005; Cifra and Pospíšil, 2014). Biological
systems spontaneously emit a measurable number of photons
within a specific range of the electromagnetic spectrum (UV
and UV/VIS) as a result of normal biochemical reactions. In
living systems, these photons are usually in the 300–750 nm
range (Bajpai et al., 2013), depending on the system. In human
tissues, the wavelength ranges from 420 to 570 nm (Wijk R.
V. and Wijk E. P., 2005). The rate of photon emissions is
generally on the order of 101–103 photons·s−1·cm−2 (Cifra
and Pospíšil, 2014), and these photons originate from oxidative
metabolic reactions and are therefore closely related to the rate
of electronic transport in mitochondria and the generation of
reactive oxygen species (ROS), reactive nitrogen species (RNS),
and/or lipid peroxidation (Kobayashi et al., 1999; Cifra and
Pospíšil, 2014; Pospíšil et al., 2014). When perturbed, these
reactions can give rise to excessive amounts of ROS, causing
damage to lipids, nucleic acids, and proteins. These damaged
biomolecules can cause a loss of cellular functions, including cell
signaling, immune responses, and pathways that regulate pro-
inflammatory and/or anti-inflammatory processes (Van Wijk
et al., 2008; Pospíšil et al., 2014), ultimately leading to cell
death.
The feasibility of recording UPE as a tool for measuring
dynamic changes in human health and various physiological
conditions has been reported (Bajpai et al., 2013; van Wijk, 2014;
VanWijk et al., 2014) andwas reviewed recently (Ives et al., 2014).
For example, a wide diversity of conditions are associated with
changes in the UPE profile, including aging (Sauermann et al.,
1999), diurnal biological rhythms (Cohen and Popp, 1997; Wijk
E. P. andWijk R. V, 2005; Cifra et al., 2007; VanWijk et al., 2007;
Kobayashi et al., 2009), and conscious activities (Van Wijk et al.,
2005, 2006, 2008). In addition, some groups have suggested that
UPE properties can be used as a diagnostic tool in measuring
health and disease (Usa et al., 1994; Cohen and Popp, 1998, 2003;
Jung et al., 2003; Yang et al., 2004).
The technology needed to continuously monitor spontaneous
UPE in the visible range in human subjects includes a sensitive
photomultiplier tube (PMT) in a sealed dark environment.
Such equipment has been developed and validated and is
now considered a rapid, relatively inexpensive, non-invasive
technology for reliably measuring UPE (Van Wijk et al., 2014).
COMBINING UPE WITH METABOLOMICS
TECHNOLOGY
The ability to combine and correlate UPE data with
metabolomics data is an essential step toward personalized
monitoring of physiological changes associated with health and
disease. In life sciences, most specialized techniques generate
profiles that provide a representative (i.e., generic) picture of
a biological system. Both metabolomics and UPE provide an
efficient readout providing valuable information regarding
the dynamics of the biological systems. The challenge is to
combine these two methodologies in order to link the detailed
biochemistry with higher organizational information. Figure 2
illustrates the four steps that are needed: sampling, analysis,
sub-grouping, and correlation. Analyzing UPE data can require
robust mathematical procedures in order to study the spatial
and/or temporal features of the signal, as well as to determine
the photon count distributions for more sophisticated analyses
(Kobayashi et al., 1998; Kobayashi and Inaba, 2000; Bajpai,
2005; Van Wijk R. et al., 2006; Bajpai et al., 2013). Finally,
the two sets of data are used to build network correlations
between UPE and metabolic profiles, which can then be used for
individual/personalized diagnostics.
As illustrated in Figure 2, this integration approach can be
exemplified in an explorative study using UPE andmetabolomics
data measured in pre-diabetic subjects. In this example,
metabolomics data was acquired using plasma samples. Samples
were analyzed using established chromatographic methodologies
using GC-MS and LC-MS (Koek et al., 2006; Draisma et al.,
2008; vanWietmarschen et al., 2013), followed by data processing
(Xia et al., 2009). UPE data were acquired from the same
subjects measuring the hands of each subject. Subsequently,
derived parameters were calculated applying photon counting
statistics (Van Wijk R. et al., 2006; Van Wijk et al., 2010; Bajpai
et al., 2013). Correlation analysis between metabolomics and
UPE data was performed using Spearman’s rank correlation
observing the correlation networks built in CytoScape with
the MetScape plugin (Shannon et al., 2003; Gao et al.,
2010). The resulting network shows correlations between the
metabolomics data and the UPE data (Figure 2). Specifically,
sugar metabolites and amine metabolites (which are related to
energy metabolism) were positively and negatively correlated,
respectively, with the UPE data (Figure 2). Lipids are known to
relate to cellular signaling and energy processes and this class
of compounds were also correlated with UPE parameters. The
outcome might indicate an essential role in both pre-diabetes
as well as the production of UPE, which is associated with
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FIGURE 2 | Overview of the experimental steps required for integrating UPE and metabolomics data in order to promote health and diagnostics. Bodily
fluids (for metabolomics; left) and parts of the body (for UPE recording; right) are sampled. The samples are analyzed using chromatographic techniques (for
metabolomics) and spatiotemporal analyses (for UPE). The metabolomics data are then gathered in pathways, and photon counting statistics is applied to the UPE
data. Finally, the two data sets are integrated performing Spearman’s rank correlations using network correlation, ultimately generating a systems-based interpretation.
In this example, plasma samples of pre-diabetic subjects (44 individuals) were analyzed for the generation metabolomics data. The metabolomics study used GC-MS
and LC-MS platforms to profile lipids (phosphatidylcholine, lysophosphatidylcholine, sphingomyelin, fatty acids, and triglycerides), organic acids, sugar metabolites,
and amine metabolites. UPE data was acquired from the subjects’ hands generating 13 parameters after applying photon count statistics. Spearman’s rank
correlations was calculated between UPE parameters and various classes of compounds acquired from the metabolomics analysis. The correlation was filtered using
|r| > 0.3 and subsequently built the correlation network using CytoScape software (MetScape plugin). Blue lines represent negative correlations, and orange lines
represent positive correlations. The study was designed and conducted by TNO (Zeist, the Netherlands). The clinical trial (https://clinicaltrials.gov/ct2/show/
NCT00469287) was approved by the Medical Ethics Committee of Tilburg (METOPP).
energy production (Tarusov et al., 1960, 1962; Barenboiˇm et al.,
1969).
Overall, the integrated platform illustrates that combining
UPE and metabolomics data is feasible and has high potential for
both measuring specific and complex information. Specifically,
integrating UPE with metabolomics contributes to our
understanding of dynamic changes and provides essential
insight into the underlying biochemistry, which enables to put
the biochemistry information (detailed field) into a broader
context and higher level of complexity. This combined approach




Here, we indicate the potential of integrating UPE and
metabolomics as a novel technology approach in order to
move our healthcare system in the direction of promoting
health in a proactive manner. Importantly, this integrated
approach combining UPE and metabolomics can provide
multi-scale information regarding key biological processes. The
clear advantage of this approach is that it will improve our
understanding of dynamic higher organizational levels while
increasing our understanding of the underlying biochemistry at
other levels. This might reveal the regulatory connection between
different time scales as occurs from the cellular to the organism
level.
The integrated information regarding metabolic activity and
complex dynamicity could possibly further provide a rapid,
robust readout of the biopsychosocial environment. In addition,
combining UPE with metabolomics technology in an integrated
platform for diagnosing both health and disease can provide an
essential first step in the direction of systems-based thinking in
personalized medicine, thereby crossing the boundaries of our
current healthcare system by shifting diagnostic focus to higher
organizational levels.
Frontiers in Physiology | www.frontiersin.org 5 December 2016 | Volume 7 | Article 611
Burgos et al. Integrating Ultra-Weak Photon Emissions with Metabolomics
AUTHOR CONTRIBUTIONS
RCRB, Jv, EV, RV conceived the manuscript. RCRB, Jv, EV,
RV, and MH wrote the manuscript. All authors reviewed the
manuscript and approved for publishing.
FUNDING
RCRB was supported by the “Science without Borders” program
of the Brazilian National Council for Scientific and Technological
Development—CNPq (Conselho Nacional de Desenvolvimento
Científico e Tecnológico) in the form of a research fellowship
awarded for PhD training in the Netherlands (fellowship number
230827/2012-8). MH was supported by the Chinese Scholarship
Council (scholarship number 20108220166).
ACKNOWLEDGMENTS
RCRB and MH thanks CNPq and the Chinese Scholarship
Council for the scholarship awarded.
REFERENCES
Academic Consortium for Integrative Medicine & Health (2016). Available online
at: http://www.imconsortium.org/
Adachi, Y., Kindzelskii, A. L., Ohno, N., Yadomae, T., and Petty, H. R. (1999).
Amplitude and frequency modulation of metabolic signals in leukocytes:
synergistic role of IFN-gamma in IL-6- and IL-2-mediated cell activation. J.
Immunol. 163, 4367–4374.
Antonovsky, A. (1984). “The sense of coherence as a determinant in health,” in
Behavioral Health: A Handbook of Health Enhancement and Disease Prevention,
ed J. D. Matarazzo (New York, NY: John Wiley), 114–129.
Bajpai, R. P. (2005). Squeezed state description of spectral decompositions
of a biophoton signal. Phys. Lett. A 337, 265–273. doi: 10.1016/
j.physleta.2005.01.079
Bajpai, R. P., Van Wijk, E. P., Van Wijk, R., and van der Greef, J. (2013). Attributes
characterizing spontaneous ultra-weak photon signals of human subjects. J.
Photochem. Photobiol. B 129, 6–16. doi: 10.1016/j.jphotobiol.2013.09.002
Barenboiˇm, G. M., Domanskiˇi, A. N., and Turoverov, K. K. (1969). Luminescence
of Biopolymers and Cells. New York, NY: Plenum.
Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A.,
Cascante, M., et al. (2016). Metabolomics enables precision medicine:
“a white paper, community perspective”. Metabolomics 12, 149.
doi: 10.1007/s11306-016-1094-6
Bircher, J. (2005). Towards a dynamic definition of health and disease.Med. Health
Care Philos. 8, 335–341. doi: 10.1007/s11019-005-0538-y
Choi, B. C., Hunter, D. J., Tsou, W., and Sainsbury, P. (2005). Diseases of comfort:
primary cause of death in the 22nd century. J. Epidemiol. Community Health
59, 1030–1034. doi: 10.1136/jech.2005.032805
Cifra, M., and Pospíšil, P. (2014). Ultra-weak photon emission from biological
samples: definition, mechanisms, properties, detection and applications. J.
Photochem. Photobiol. B 139, 2–10. doi: 10.1016/j.jphotobiol.2014.02.009
Cifra, M., Van Wijk, E., Koch, H., Bosman, S., and Van Wijk, R. (2007).
Spontaneous ultra-weak photon emission from human hands is time
dependent. Radioengineering 16, 15–19.
Cohen, S., and Popp, F. A. (1997). Low-level luminescence of the human skin. Skin
Res. Technol. 3, 177–180. doi: 10.1111/j.1600-0846.1997.tb00184.x
Cohen, S., and Popp, F. A. (1998). “Whole-body counting of biophotons and its
relation to biological rhythms,” in Biophotons, eds J.-J. Chang, J. Fisch, and F.-A.
Popp (Dordrecht: Springer Netherlands), 183–191.
Cohen, S., and Popp, F. A. (2003). Biophoton emission of human body. Indian J.
Exp. Biol. 41, 440–445.
de Mello Gallep, C. (2014). Ultraweak, spontaneous photon emission in seedlings:
toxicological and chronobiological applications. Luminescence 29, 963–968.
doi: 10.1002/bio.2658
Devaraj, B., Usa, M., and Inaba, H. (1997). Biophotons: ultraweak light
emission from living systems. Curr. Opin. Solid State Mater. Sci. 2, 188–193.
doi: 10.1016/S1359-0286(97)80064-2
Draisma, H. H., Reijmers, T. H., Bobeldijk-Pastorova, I., Meulman, J. J., Estourgie-
Van Burk, G. F., Bartels, M., et al. (2008). Similarities and differences in
lipidomics profiles among healthy monozygotic twin pairs. OMICS 12, 17–31.
doi: 10.1089/omi.2007.0048
Gao, J., Tarcea, V. G., Karnovsky, A., Mirel, B. R., Weymouth, T. E., Beecher, C.
W., et al. (2010). Metscape: a Cytoscape plug-in for visualizing and interpreting
metabolomic data in the context of human metabolic networks. Bioinformatics
26, 971–973. doi: 10.1093/bioinformatics/btq048
German, J. B., Hammock, B. D., andWatkins, S.M. (2005).Metabolomics: building
on a century of biochemistry to guide human health. Metabolomics 1, 3–9.
doi: 10.1007/s11306-005-1102-8
Hood, L., and Friend, S. H. (2011). Predictive, personalized, preventive,
participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8, 184–187.
doi: 10.1038/nrclinonc.2010.227
Huber, M., Knottnerus, J. A., Green, L., van der Horst, H., Jadad, A. R.,
Kromhout, D., et al. (2011). How should we define health? BMJ 343:d4163.
doi: 10.1136/bmj.d4163
Hunter, D. J. (2008). Health needs more than health care: the need for a new
paradigm. Eur. J. Public Health 18, 217–219. doi: 10.1093/eurpub/ckn039
Ives, J. A., Van Wijk, E. P., Bat, N., Crawford, C., Walter, A., Jonas, W. B.,
et al. (2014). Ultraweak photon emission as a non-invasive health assessment:
a systematic review. PLoS ONE 9:e87401. doi: 10.1371/journal.pone.00
87401
Jung, H. H., Woo, W. M., Yang, J. M., Choi, C., Lee, J., Yoon, G., et al. (2003).
Left-right asymmetry of biophoton emission from hemiparesis patients. Indian
J. Exp. Biol. 41, 452–456.
Kobayashi, M., Devaraj, B., and Inaba, H. (1998). Observation of super-
Poisson statistics of bacterial (Photobacterium phosphoreum) bioluminescence
during the early stage of cell proliferation. Phys. Rev. E 57, 2129–2133.
doi: 10.1103/PhysRevE.57.2129
Kobayashi, M., and Inaba, H. (2000). Photon statistics and correlation
analysis of ultraweak light originating from living organisms for extraction
of biological information. Appl. Opt. 39, 183–192. doi: 10.1364/AO.39.
000183
Kobayashi, M., Kikuchi, D., and Okamura, H. (2009). Imaging of ultraweak
spontaneous photon emission from human body displaying diurnal rhythm.
PLoS ONE 4:e6256. doi: 10.1371/journal.pone.0006256
Kobayashi, M., Takeda, M., Sato, T., Yamazaki, Y., Kaneko, K., Ito, K., et al. (1999).
In vivo imaging of spontaneous ultraweak photon emission from a rat’s brain
correlated with cerebral energy metabolism and oxidative stress. Neurosci. Res.
34, 103–113. doi: 10.1016/S0168-0102(99)00040-1
Koek, M. M., Muilwijk, B., van der Werf, M. J., and Hankemeier, T. (2006).
Microbial metabolomics with gas chromatography/mass spectrometry. Anal.
Chem. 78, 1272–1281. doi: 10.1021/ac051683+
Lancet, T. (2009). What is health? The ability to adapt. Lancet 373, 781.
doi: 10.1016/s0140-6736(09)60456-6
Layard, R. (2005). Happiness: Lessons from a New Science. London: Penguin Press.
Lindstrom, B., and Eriksson, M. (2005). Salutogenesis. J. Epidemiol. Community
Health 59, 440–442. doi: 10.1136/jech.2005.034777
Most, E. I., Scheltens, P., and Van Someren, E. J. (2010). Prevention of depression
and sleep disturbances in elderly with memory-problems by activation of
the biological clock with light–a randomized clinical trial. Trials 11:19.
doi: 10.1186/1745-6215-11-19
Muehsam, D., and Ventura, C. (2014). Life rhythm as a symphony of
oscillatory patterns: electromagnetic energy and sound vibration modulates
gene expression for biological signaling and healing. Glob. Adv. Health Med.
3, 40–55. doi: 10.7453/gahmj.2014.008
Oltvai, Z. N., and Barabási, A. L. (2002). Systems biology. Life’s complexity
pyramid. Science 298, 763–764. doi: 10.1126/science.1078563
Frontiers in Physiology | www.frontiersin.org 6 December 2016 | Volume 7 | Article 611
Burgos et al. Integrating Ultra-Weak Photon Emissions with Metabolomics
Pospíšil, P., Prasad, A., and Rac, M. (2014). Role of reactive oxygen species in ultra-
weak photon emission in biological systems. J. Photochem. Photobiol. B 139,
11–23. doi: 10.1016/j.jphotobiol.2014.02.008
Puska, P. (2008). What are the drivers of the new paradigm? Eur. J. Public Health
18, 219. doi: 10.1093/eurpub/ckn042
Ramautar, R., Berger, R., van der Greef, J., and Hankemeier, T. (2013). Human
metabolomics: strategies to understand biology. Curr. Opin. Chem. Biol. 17,
841–846. doi: 10.1016/j.cbpa.2013.06.015
Sauermann, G., Mei, W. P., Hoppe, U., and Stäb, F. (1999). Ultraweak
photon emission of human skin in vivo: influence of topically
applied antioxidants on human skin. Methods Enzymol. 300, 419–428.
doi: 10.1016/S0076-6879(99)00147-0
Schwabl, H., and Klima, H. (2005). Spontaneous ultraweak photon emission from
biological systems and the endogenous light field. Forsch. Komplementarmed.
Klass. Naturheilkd. 12, 84–89. doi: 10.1159/000083960
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage,
D., et al. (2003). Cytoscape: a software environment for integrated
models of biomolecular interaction networks. Genome Res. 13, 2498–2504.
doi: 10.1101/gr.1239303
Snyderman, R. (2012). Personalized health care: from theory to practice.
Biotechnol. J. 7, 973–979. doi: 10.1002/biot.201100297
Sterling, P. (2012). Allostasis: a model of predictive regulation. Physiol. Behav. 106,
5–15. doi: 10.1016/j.physbeh.2011.06.004
Tarusov, B., Polivoda, A. I., and Zhuravlev, A. I. (1960). [Study on ultra-weak
spontaneous luminescence of animal cells.]. Biofizika 6, 490–492.
Tarusov, B. N., Polivoda, A. I., Zhuravlev, A. I., and Sekamova, E. N. (1962).
[Ultraweak spontaneous luminescence in animal tissue]. Tsitologiia 4, 696–699.
Usa, M., Devaraj, B., Kobayashi, M., Takeda, M., Ito, H., Jin, M., et al. (1994).
“Detection and characterization of ultraweak biophotons from life processes,”
inOptical Methods in Biomedical and Environmental Sciences, eds H. Ohzu and
S. Komatsu (Amsterdam: Elsevier Science), 3–6.
van der Greef, J., Hankemeier, T., and McBurney, R. N. (2006).
Metabolomics-based systems biology and personalized medicine:
moving towards n = 1 clinical trials? Pharmacogenomics 7, 1087–1094.
doi: 10.2217/14622416.7.7.1087
van der Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R.,
et al. (2007). The art and practice of systems biology in medicine: mapping
patterns of relationships. J. Proteome Res. 6, 1540–1559. doi: 10.1021/pr0606530
van der Greef, J., van Wietmarschen, H., Schroën, J., Wang, M., Hankemeier,
T., and Xu, G. (2010). Systems biology-based diagnostic principles as pillars
of the bridge between Chinese and Western medicine. Planta Med. 76, 2036.
doi: 10.1055/s-0030-1250450
van der Greef, J., van Wietmarschen, H., van Ommen, B., and Verheij, E. (2013).
Looking back into the future: 30 years of metabolomics at TNO.Mass Spectrom.
Rev. 32, 399–415. doi: 10.1002/mas.21370
van Ommen, B., van der Greef, J., Ordovas, J. M., and Daniel, H. (2014).
Phenotypic flexibility as key factor in the human nutrition and health
relationship. Genes Nutr. 9, 423. doi: 10.1007/s12263-014-0423-5
van Wietmarschen, H. A., van der Greef, J., Schroën, Y., and Wang,
M. (2013). Evaluation of symptom, clinical chemistry and metabolomics
profiles during Rehmannia six formula (R6) treatment: an integrated and
personalized data analysis approach. J. Ethnopharmacol. 150, 851–859.
doi: 10.1016/j.jep.2013.09.041
Van Wijk, E. P., Ackerman, J., and Van Wijk, R. (2005). Effect of meditation
on ultraweak photon emission from hands and forehead. Forsch.
Komplementarmed. Klass. Naturheilkd. 12, 107–112. doi: 10.1159/000084028
Van Wijk, E. P., Koch, H., Bosman, S., and Van Wijk, R. (2006). Anatomic
characterization of human ultra-weak photon emission in practitioners of
transcendental meditation(TM) and control subjects. J. Altern. Complement.
Med. 12, 31–38. doi: 10.1089/acm.2006.12.31
Van Wijk, E. P., Lüdtke, R., and Van Wijk, R. (2008). Differential effects of
relaxation techniques on ultraweak photon emission. J. Altern. Complement.
Med. 14, 241–250. doi: 10.1089/acm.2007.7185
Van Wijk, E. P., Wijk, R. V., Bajpai, R. P., and van der Greef, J. (2010). Statistical
analysis of the spontaneously emitted photon signals from palm and dorsal
sides of both hands in human subjects. J. Photochem. Photobiol. B 99, 133–143.
doi: 10.1016/j.jphotobiol.2010.03.008
Van Wijk, E. P. A., Van Wijk, R., and Cifra, M. (2007). “Spontaneous ultra-weak
photon emission from human hands varies diurnally,” in Proceedings of SPIE –
OSA Biomedical Optics – Vol. 6633_54 Biophotonics 2007: Optics in Life Science,
eds J. Popp and G. von Bally (Munich).
van Wijk, R. (2014). Light in Shaping Life-Biophotons in Biology and Medicine.
Geldermalsen: Meluna Research.
Van Wijk, R., Van Wijk, E. P., and Bajpai, R. P. (2006). Photocount distribution of
photons emitted from three sites of a human body. J. Photochem. Photobiol. B
84, 46–55. doi: 10.1016/j.jphotobiol.2006.01.010
Van Wijk, R., Van Wijk, E. P., Van Wietmarschen, H. A., and Van der Greef, J.
(2014). Towards whole-body ultra-weak photon counting and imaging with
a focus on human beings: a review. J. Photochem. Photobiol. B 139, 39–46.
doi: 10.1016/j.jphotobiol.2013.11.014
Van Wijk, R., Van Wijk, E. P., Wiegant, F. A., and Ives, J. (2008). Free radicals and
low-level photon emission in human pathogenesis: state of the art. Indian J.
Exp. Biol. 46, 273–309.
Wijk, E. P., and Wijk, R. V. (2005). Multi-site recording and spectral analysis of
spontaneous photon emission from human body. Forsch. Komplementarmed.
Klass. Naturheilkd. 12, 96–106. doi: 10.1159/000083935
Wijk, R. V., and Wijk, E. P. (2005). An introduction to human biophoton
emission. Forsch. Komplementarmed. Klass. Naturheilkd. 12, 77–83.
doi: 10.1159/000083763
Wopereis, S., Rubingh, C. M., van Erk, M. J., Verheij, E. R., van Vliet, T.,
Cnubben, N. H., et al. (2009). Metabolic profiling of the response to an oral
glucose tolerance test detects subtle metabolic changes. PLoS ONE 4:e4525.
doi: 10.1371/journal.pone.0004525
Xia, J., Psychogios, N., Young, N., andWishart, D. S. (2009). MetaboAnalyst: a web
server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37,
W652–W660. doi: 10.1093/nar/gkp356
Yang, J. M., Choi, C., Hyun-hee., Woo, W. M., Yi, S. H., Soh, K. S.,
et al. (2004). Left-right and Yin-Yang balance of biophoton emission from
hands. Acupunct. Electrother. Res. 29, 197–211. doi: 10.3727/0360129048159
01425
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Burgos, van Wijk, van Wijk, He and van der Greef. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Physiology | www.frontiersin.org 7 December 2016 | Volume 7 | Article 611
